Oaktree Capital Management »

Indivior Pharmaceuticals shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $213M 7.0M 30.48

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Expand Energy Corp Common Stock (EXE)
Invesco Qqq Trust Series 1 Etf Put Option (QQQ)
Anglogold Ashanti Common Stock (AU)
Garrett Motion Common Stock (GTX)
Indivior Pharmaceuticals Common Stock (INDV)
Core Scientific Common Stock Call Option (CORZ)
State Street Spdr S&p Oil & Gas Exploration & Production Etf Etf Put Option (XOP)
Telephone And Data Systems Common Stock (TDS)
Viper Energy Common Stock (VNOM)
Talen Energy Corp Common Stock Call Option (TLN)
Sunopta Common Stock (STKL)
Petroleo Brasileiro Sa - Petrobras Common Stock (PBR)
Barrick Mining Corp Common Stock (B)
Liberty Global Common Stock (LBTYA)

View all positions for Oaktree Capital Management

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals